Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399308 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00399308 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 40 participants.
The verdict
NCT00399308, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This pilot study was designed to test the safety of Celaderm(TM) in treating venous leg ulcers and to give preliminary information about the efficacy of two different Celaderm(TM) dosing regimens.
Interventions
- DEVICE Celaderm (Frozen Cultured Epidermal Allograft)
- DEVICE Control (compression bandaging)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-01-31 |
| Est. Completion | 2008-04-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399308
The ClinicalTrials.gov registry entry for NCT00399308 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Celaderm (Frozen Cultured Epidermal Allograft) is the first listed.
NCT00399308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399308 about?
NCT00399308 is a clinical study titled "Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers". This pilot study was designed to test the safety of Celaderm(TM) in treating venous leg ulcers and to give preliminary information about the efficacy of two different Celaderm(TM) dosing regimens.
What is the current status of trial NCT00399308?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2007-01-31. Estimated completion is 2008-04-30.
What interventions are being tested in trial NCT00399308?
The interventions under investigation include: Celaderm (Frozen Cultured Epidermal Allograft) (DEVICE), Control (compression bandaging) (DEVICE).
Who is sponsoring clinical trial NCT00399308?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.